AAV5 anticorps
-
- Antigène Tous les produits AAV5
- AAV5 (Adeno-Associated Virus 5 (AAV5))
- Reactivité
- Adeno-Associated Virus 5 (AAV-5)
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp AAV5 est non-conjugé
-
Application
- Western Blotting (WB)
- Immunogène
- AAV5 antibody was raised in rabbit using AAV-5 capsid proteins as the immunogen.
-
-
- Indications d'application
- WB: 1:300-1000, IHC: 1:50-1:100, IF: 1:100-1:500, ELISA: 1:5000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- liquid form, dilute with PBS before use
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
- Stock
- -20 °C
- Stockage commentaire
- Store at 2-8 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy." dans: Molecular therapy. Methods & clinical development, Vol. 13, pp. 440-452, (2019) (PubMed).
: "Strategy to detect pre-existing immunity to AAV gene therapy." dans: Gene therapy, Vol. 24, Issue 12, pp. 768-778, (2018) (PubMed).
: "
-
The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy." dans: Molecular therapy. Methods & clinical development, Vol. 13, pp. 440-452, (2019) (PubMed).
-
- Antigène
- AAV5 (Adeno-Associated Virus 5 (AAV5))
- Autre désignation
- AAV 5 (AAV5 Produits)
- Classe de substances
- Virus
-